Ready-to-use tool for oncology
Pharmacists have a new oncology-focused tool for the evaluation and assessment of adverse drug events in oncology.
French researchers have developed a trigger tool to...
Call for pharmacist access to the MBS for Chronic Disease Management
Pharmacists within general practice is a positive step forward, but the exclusion from MBS Team Care arrangements in CDM items makes no sense.
After a...
Diclofenac associated with cardiovascular health risk
A 20-year population-based study has found the use of diclofenac for pain relief is linked to an increased risk of major adverse cardiovascular events...
Harnessing different abilities
Some might assume employing someone with a declared disability would only bring complications. But some community pharmacies around Australia are leading the way in...
Q&A: Shadow Federal Health Minister Catherine King
As a supporter of pharmacists, Catherine King MP is a firm believer in having a ‘broader’ role for pharmacists in Australia’s health system.
During her...
Treating hypertension – a new approach
Hypertension is the leading cause of cardiovascular disease, affecting 1.13 billion people worldwide, including six million adult Australians.
Research has indicated that a new pharmacological...
